Trial Profile
A Phase I Open-Label Trial to Investigate the Effect of Severe Renal Impairment on the Single-Dose Pharmacokinetics of Telaprevir.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2010
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 26 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Feb 2010 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.